跳至主要内容
临床试验/NCT02786095
NCT02786095招募中不适用

Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation (AF) (Code-AF Trial)

Yonsei University1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20,000
试验地点
1
主要终点
number of hospitalization by heart failure

研究概览

简要总结

This study is prospective Cohort study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is all patients with atrial fibrillation who visit hospital. The purpose is to analyze complication, composite outcome (all cause mortality, hospitalization, the incidence of stroke, heart failure and cardiovascular event (MACE)) according to the 1) the use of anti-arrhythmic drugs (AADs), 2) use of medication for rate control (beta blocker, calcium channel blocker and digoxin) and 3) use of anticoagulation agents (warfarin, coumadin, an NOAC)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with atrial fibrillation
  • patients with age more than 19
  • patients who agree with study inclusion

排除标准

  • patients who do not agree with study inclusion
  • patients with age less than 19
  • Pregnancy, Breastfeeding

结局指标

主要结局

number of hospitalization by heart failure

时间窗: 3 years

number of recurrent stroke

时间窗: 3 years

number of cardiovascular events

时间窗: 3 years

all cause mortality

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验